The use of amantadine HCL in clinical practice: A study of old and new indications

Carlos Singer, Spiridon Papapetropoulos, Gadith Uzcategui, Lydia Vela

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Since the discovery of the anti-dyskinetic properties of amantadine, there has been a renewed interest in its use. To evaluate its efficacy and tolerability, we performed a retrospective study of consecutive patients with Parkinson's disease (PD) who had received amantadine either as mono- or combination therapy for a 3-year period. We identified 41 patients. Nineteen (46%) experienced amantadine-related side effects. Eleven (27%) discontinued treatment before 1 year. Although dyskinesias improved (to some extent) in all patients after amantadine treatment, only 73.3% experienced improvement of motor symptoms. In conclusion, amantadine was effective in the treatment PD for at least 1 year in 40% of our patients.

Original languageEnglish
Pages (from-to)240-245
Number of pages6
JournalJournal of Applied Research
Volume6
Issue number3
StatePublished - Nov 21 2006

Fingerprint

Amantadine
Parkinson Disease
Dyskinesias
Therapeutics
Retrospective Studies

Keywords

  • Amantadine
  • Clinical practice
  • Dyskinesias
  • Side-effects

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology

Cite this

The use of amantadine HCL in clinical practice : A study of old and new indications. / Singer, Carlos; Papapetropoulos, Spiridon; Uzcategui, Gadith; Vela, Lydia.

In: Journal of Applied Research, Vol. 6, No. 3, 21.11.2006, p. 240-245.

Research output: Contribution to journalArticle

Singer, C, Papapetropoulos, S, Uzcategui, G & Vela, L 2006, 'The use of amantadine HCL in clinical practice: A study of old and new indications', Journal of Applied Research, vol. 6, no. 3, pp. 240-245.
Singer, Carlos ; Papapetropoulos, Spiridon ; Uzcategui, Gadith ; Vela, Lydia. / The use of amantadine HCL in clinical practice : A study of old and new indications. In: Journal of Applied Research. 2006 ; Vol. 6, No. 3. pp. 240-245.
@article{e607280b845d47238968e9114c736797,
title = "The use of amantadine HCL in clinical practice: A study of old and new indications",
abstract = "Since the discovery of the anti-dyskinetic properties of amantadine, there has been a renewed interest in its use. To evaluate its efficacy and tolerability, we performed a retrospective study of consecutive patients with Parkinson's disease (PD) who had received amantadine either as mono- or combination therapy for a 3-year period. We identified 41 patients. Nineteen (46{\%}) experienced amantadine-related side effects. Eleven (27{\%}) discontinued treatment before 1 year. Although dyskinesias improved (to some extent) in all patients after amantadine treatment, only 73.3{\%} experienced improvement of motor symptoms. In conclusion, amantadine was effective in the treatment PD for at least 1 year in 40{\%} of our patients.",
keywords = "Amantadine, Clinical practice, Dyskinesias, Side-effects",
author = "Carlos Singer and Spiridon Papapetropoulos and Gadith Uzcategui and Lydia Vela",
year = "2006",
month = "11",
day = "21",
language = "English",
volume = "6",
pages = "240--245",
journal = "Journal of Applied Research",
issn = "1537-064X",
publisher = "The Journal of Applied Research",
number = "3",

}

TY - JOUR

T1 - The use of amantadine HCL in clinical practice

T2 - A study of old and new indications

AU - Singer, Carlos

AU - Papapetropoulos, Spiridon

AU - Uzcategui, Gadith

AU - Vela, Lydia

PY - 2006/11/21

Y1 - 2006/11/21

N2 - Since the discovery of the anti-dyskinetic properties of amantadine, there has been a renewed interest in its use. To evaluate its efficacy and tolerability, we performed a retrospective study of consecutive patients with Parkinson's disease (PD) who had received amantadine either as mono- or combination therapy for a 3-year period. We identified 41 patients. Nineteen (46%) experienced amantadine-related side effects. Eleven (27%) discontinued treatment before 1 year. Although dyskinesias improved (to some extent) in all patients after amantadine treatment, only 73.3% experienced improvement of motor symptoms. In conclusion, amantadine was effective in the treatment PD for at least 1 year in 40% of our patients.

AB - Since the discovery of the anti-dyskinetic properties of amantadine, there has been a renewed interest in its use. To evaluate its efficacy and tolerability, we performed a retrospective study of consecutive patients with Parkinson's disease (PD) who had received amantadine either as mono- or combination therapy for a 3-year period. We identified 41 patients. Nineteen (46%) experienced amantadine-related side effects. Eleven (27%) discontinued treatment before 1 year. Although dyskinesias improved (to some extent) in all patients after amantadine treatment, only 73.3% experienced improvement of motor symptoms. In conclusion, amantadine was effective in the treatment PD for at least 1 year in 40% of our patients.

KW - Amantadine

KW - Clinical practice

KW - Dyskinesias

KW - Side-effects

UR - http://www.scopus.com/inward/record.url?scp=33751051941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751051941&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33751051941

VL - 6

SP - 240

EP - 245

JO - Journal of Applied Research

JF - Journal of Applied Research

SN - 1537-064X

IS - 3

ER -